Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Neurovascular Stent Market by Product Type (Carotid artery stents, Intracranial stents), by Material (Metal, Polymer) and by End Users (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03273

Pages: NA

Charts: NA

Tables: NA

A neurovascular stent is a small, tube-like, flexible device that is made of either metal or polymer. The device is utilized to treat several conditions in the brain such as stenosis formation in the blood vessels and ischemic stroke. The neurovascular stents are used for thrombectomy as they have the ability to rapidly restore the blood flow in an acute embolic stroke. Globally, ischemic stroke is the major cause of disability and mortality.

High incidence rates of neurovascular disorders and rise in disorders such as ischemic stroke, stenosis, brain aneurysm, and other illnesses are the major driving factors for the market growth. Furthermore, growth in unhealthy diet, excessive alcohol consumption, smoking, less physical activity, and stress has increased the incidence of cerebral aneurysms. In addition, high incidence of blood pressure has increased the risk of suffering from a ruptured aneurysm.

Moreover, a rise in the emergence of neurovascular stents with new technology will drive the market growth during the forecast period. The growing use of nitinol-based neurovascular stents due to its advantages such as superelasticity will help boost the market growth. When compared with other materials such as stainless steel and polymers, nitinol offers excellent biocompatibility, recovering elongation, and visibility.

The global neurovascular stent market is segmented based on product type, material, end users, and geography. Based on product type, the market is bifurcated into carotid artery stents and intracranial stents. Based on material, the market is categorized into metal and polymer. Metal is further divided into stainless steel and nitinol. Based on end users, it is segmented into hospitals, ambulatory surgical centers, and others. Based on geography, the market has been examined across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Abbott Laboratories, Gore Medical, Terumo Medical, Johnson & Johnson, Medtronic, Acandis, Stryker, MicroPort Scientific, Cordis, and MicroPort Scientific have also been provided in this report.

Key Benefits

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global market.
  • This report entails a detailed quantitative analysis of the current market and estimations which assists in identifying prevailing market opportunities.
  • The projections in this report are made by analyzing the current trends and future market potential in terms of value.
  • Competitive intelligence (of leading manufacturers and distributors of neurovascular stents) helps understand the competitive scenario globally.
  • An in-depth analysis of current research and clinical developments within the market has been provided with key market dynamic factors that help understand the behavior of the market.

 Key Market Segments

  • By Product Type
    • Carotid artery stents
    • Intracranial stents
  • By Material
    • Metal
      • Stainless steel
      • Nitinol
    • Polymer
  • By End Users
    • Hospitals
    • Ambulatory Surgical Centers
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Johnson & Johnson
  • Cordis
  • Acandis
  • Abbott Laboratories
  • Terumo Medical
  • Gore Medical
  • Medtronic
  • Boston Scientific Corporation
  • Stryker
  • MicroPort Scientific

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: NEUROVASCULAR STENT MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Carotid Artery Stents

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Intracranial Stents

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: NEUROVASCULAR STENT MARKET, BY MATERIAL

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Material

    • 5.2. Metal

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

      • 5.2.4. Stainless steel

        • 5.2.4.1. Market Size and Forecast

      • 5.2.4. Nitinol

        • 5.2.4.1. Market Size and Forecast

    • 5.3. Polymer

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: NEUROVASCULAR STENT MARKET, BY END USERS

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End Users

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Ambulatory Surgical Centers

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Others

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: NEUROVASCULAR STENT MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product Type

      • 7.2.3. Market Size and Forecast, By Material

      • 7.2.4. Market Size and Forecast, By End Users

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Neurovascular Stent Market

        • 7.2.6.1. Market Size and Forecast, By Product Type
        • 7.2.6.2. Market Size and Forecast, By Material
        • 7.2.6.3. Market Size and Forecast, By End Users

      • 7.2.7. Canada Neurovascular Stent Market

        • 7.2.7.1. Market Size and Forecast, By Product Type
        • 7.2.7.2. Market Size and Forecast, By Material
        • 7.2.7.3. Market Size and Forecast, By End Users

      • 7.2.8. Mexico Neurovascular Stent Market

        • 7.2.8.1. Market Size and Forecast, By Product Type
        • 7.2.8.2. Market Size and Forecast, By Material
        • 7.2.8.3. Market Size and Forecast, By End Users

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product Type

      • 7.3.3. Market Size and Forecast, By Material

      • 7.3.4. Market Size and Forecast, By End Users

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Neurovascular Stent Market

        • 7.3.6.1. Market Size and Forecast, By Product Type
        • 7.3.6.2. Market Size and Forecast, By Material
        • 7.3.6.3. Market Size and Forecast, By End Users

      • 7.3.7. Germany Neurovascular Stent Market

        • 7.3.7.1. Market Size and Forecast, By Product Type
        • 7.3.7.2. Market Size and Forecast, By Material
        • 7.3.7.3. Market Size and Forecast, By End Users

      • 7.3.8. Italy Neurovascular Stent Market

        • 7.3.8.1. Market Size and Forecast, By Product Type
        • 7.3.8.2. Market Size and Forecast, By Material
        • 7.3.8.3. Market Size and Forecast, By End Users

      • 7.3.9. Spain Neurovascular Stent Market

        • 7.3.9.1. Market Size and Forecast, By Product Type
        • 7.3.9.2. Market Size and Forecast, By Material
        • 7.3.9.3. Market Size and Forecast, By End Users

      • 7.3.10. UK Neurovascular Stent Market

        • 7.3.10.1. Market Size and Forecast, By Product Type
        • 7.3.10.2. Market Size and Forecast, By Material
        • 7.3.10.3. Market Size and Forecast, By End Users

      • 7.3.11. Russia Neurovascular Stent Market

        • 7.3.11.1. Market Size and Forecast, By Product Type
        • 7.3.11.2. Market Size and Forecast, By Material
        • 7.3.11.3. Market Size and Forecast, By End Users

      • 7.3.12. Rest Of Europe Neurovascular Stent Market

        • 7.3.12.1. Market Size and Forecast, By Product Type
        • 7.3.12.2. Market Size and Forecast, By Material
        • 7.3.12.3. Market Size and Forecast, By End Users

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product Type

      • 7.4.3. Market Size and Forecast, By Material

      • 7.4.4. Market Size and Forecast, By End Users

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Neurovascular Stent Market

        • 7.4.6.1. Market Size and Forecast, By Product Type
        • 7.4.6.2. Market Size and Forecast, By Material
        • 7.4.6.3. Market Size and Forecast, By End Users

      • 7.4.7. Japan Neurovascular Stent Market

        • 7.4.7.1. Market Size and Forecast, By Product Type
        • 7.4.7.2. Market Size and Forecast, By Material
        • 7.4.7.3. Market Size and Forecast, By End Users

      • 7.4.8. India Neurovascular Stent Market

        • 7.4.8.1. Market Size and Forecast, By Product Type
        • 7.4.8.2. Market Size and Forecast, By Material
        • 7.4.8.3. Market Size and Forecast, By End Users

      • 7.4.9. South Korea Neurovascular Stent Market

        • 7.4.9.1. Market Size and Forecast, By Product Type
        • 7.4.9.2. Market Size and Forecast, By Material
        • 7.4.9.3. Market Size and Forecast, By End Users

      • 7.4.10. Australia Neurovascular Stent Market

        • 7.4.10.1. Market Size and Forecast, By Product Type
        • 7.4.10.2. Market Size and Forecast, By Material
        • 7.4.10.3. Market Size and Forecast, By End Users

      • 7.4.11. Thailand Neurovascular Stent Market

        • 7.4.11.1. Market Size and Forecast, By Product Type
        • 7.4.11.2. Market Size and Forecast, By Material
        • 7.4.11.3. Market Size and Forecast, By End Users

      • 7.4.12. Malaysia Neurovascular Stent Market

        • 7.4.12.1. Market Size and Forecast, By Product Type
        • 7.4.12.2. Market Size and Forecast, By Material
        • 7.4.12.3. Market Size and Forecast, By End Users

      • 7.4.13. Indonesia Neurovascular Stent Market

        • 7.4.13.1. Market Size and Forecast, By Product Type
        • 7.4.13.2. Market Size and Forecast, By Material
        • 7.4.13.3. Market Size and Forecast, By End Users

      • 7.4.14. Rest of Asia Pacific Neurovascular Stent Market

        • 7.4.14.1. Market Size and Forecast, By Product Type
        • 7.4.14.2. Market Size and Forecast, By Material
        • 7.4.14.3. Market Size and Forecast, By End Users

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product Type

      • 7.5.3. Market Size and Forecast, By Material

      • 7.5.4. Market Size and Forecast, By End Users

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Neurovascular Stent Market

        • 7.5.6.1. Market Size and Forecast, By Product Type
        • 7.5.6.2. Market Size and Forecast, By Material
        • 7.5.6.3. Market Size and Forecast, By End Users

      • 7.5.7. South Africa Neurovascular Stent Market

        • 7.5.7.1. Market Size and Forecast, By Product Type
        • 7.5.7.2. Market Size and Forecast, By Material
        • 7.5.7.3. Market Size and Forecast, By End Users

      • 7.5.8. Saudi Arabia Neurovascular Stent Market

        • 7.5.8.1. Market Size and Forecast, By Product Type
        • 7.5.8.2. Market Size and Forecast, By Material
        • 7.5.8.3. Market Size and Forecast, By End Users

      • 7.5.9. UAE Neurovascular Stent Market

        • 7.5.9.1. Market Size and Forecast, By Product Type
        • 7.5.9.2. Market Size and Forecast, By Material
        • 7.5.9.3. Market Size and Forecast, By End Users

      • 7.5.10. Argentina Neurovascular Stent Market

        • 7.5.10.1. Market Size and Forecast, By Product Type
        • 7.5.10.2. Market Size and Forecast, By Material
        • 7.5.10.3. Market Size and Forecast, By End Users

      • 7.5.11. Rest of LAMEA Neurovascular Stent Market

        • 7.5.11.1. Market Size and Forecast, By Product Type
        • 7.5.11.2. Market Size and Forecast, By Material
        • 7.5.11.3. Market Size and Forecast, By End Users

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Abbott Laboratories

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Gore Medical

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Terumo Medical

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Johnson And Johnson

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Medtronic

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Acandis

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Stryker

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. MicroPort Scientific

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Cordis

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Boston Scientific Corporation

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NEUROVASCULAR STENT MARKET, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL NEUROVASCULAR STENT MARKET FOR CAROTID ARTERY STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL NEUROVASCULAR STENT MARKET FOR INTRACRANIAL STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR STENT MARKET, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL NEUROVASCULAR STENT MARKET FOR METAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL NEUROVASCULAR STENT MARKET FOR POLYMER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL NEUROVASCULAR STENT MARKET, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL NEUROVASCULAR STENT MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL NEUROVASCULAR STENT MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL NEUROVASCULAR STENT MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL NEUROVASCULAR STENT MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA NEUROVASCULAR STENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 16. U.S. NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 17. U.S. NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 18. U.S. NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 19. CANADA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 20. CANADA NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 21. CANADA NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 22. MEXICO NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 23. MEXICO NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 24. MEXICO NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 25. EUROPE NEUROVASCULAR STENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 26. EUROPE NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 29. FRANCE NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 30. FRANCE NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 31. FRANCE NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 32. GERMANY NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 33. GERMANY NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 34. GERMANY NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 35. ITALY NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 36. ITALY NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 37. ITALY NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 38. SPAIN NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 39. SPAIN NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 40. SPAIN NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 41. UK NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 42. UK NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 43. UK NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 44. RUSSIA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 45. RUSSIA NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 46. RUSSIA NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 47. REST OF EUROPE NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 48. REST OF EUROPE NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 49. REST OF EUROPE NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 50. ASIA-PACIFIC NEUROVASCULAR STENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 51. ASIA-PACIFIC NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 52. ASIA-PACIFIC NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 53. ASIA-PACIFIC NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 54. CHINA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 55. CHINA NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 56. CHINA NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 57. JAPAN NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 58. JAPAN NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 59. JAPAN NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 60. INDIA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 61. INDIA NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 62. INDIA NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH KOREA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 64. SOUTH KOREA NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 65. SOUTH KOREA NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 66. AUSTRALIA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 67. AUSTRALIA NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 68. AUSTRALIA NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 69. THAILAND NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 70. THAILAND NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 71. THAILAND NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 72. MALAYSIA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 73. MALAYSIA NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 74. MALAYSIA NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 75. INDONESIA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 76. INDONESIA NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 77. INDONESIA NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 78. REST OF ASIA PACIFIC NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 79. REST OF ASIA PACIFIC NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 80. REST OF ASIA PACIFIC NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 81. LAMEA NEUROVASCULAR STENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 82. LAMEA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 83. LAMEA NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 84. LAMEA NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 85. BRAZIL NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 86. BRAZIL NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 87. BRAZIL NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 88. SOUTH AFRICA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 89. SOUTH AFRICA NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 90. SOUTH AFRICA NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 91. SAUDI ARABIA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 92. SAUDI ARABIA NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 93. SAUDI ARABIA NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 94. UAE NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 95. UAE NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 96. UAE NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 97. ARGENTINA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 98. ARGENTINA NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 99. ARGENTINA NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 100. REST OF LAMEA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 101. REST OF LAMEA NEUROVASCULAR STENT, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 102. REST OF LAMEA NEUROVASCULAR STENT, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 103. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 104. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 105. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 106. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 107. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. GORE MEDICAL: KEY EXECUTIVES
  • TABLE 109. GORE MEDICAL: COMPANY SNAPSHOT
  • TABLE 110. GORE MEDICAL: OPERATING SEGMENTS
  • TABLE 111. GORE MEDICAL: PRODUCT PORTFOLIO
  • TABLE 112. GORE MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. TERUMO MEDICAL: KEY EXECUTIVES
  • TABLE 114. TERUMO MEDICAL: COMPANY SNAPSHOT
  • TABLE 115. TERUMO MEDICAL: OPERATING SEGMENTS
  • TABLE 116. TERUMO MEDICAL: PRODUCT PORTFOLIO
  • TABLE 117. TERUMO MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. JOHNSON AND JOHNSON: KEY EXECUTIVES
  • TABLE 119. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 120. JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 121. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 122. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. MEDTRONIC: KEY EXECUTIVES
  • TABLE 124. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 125. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 126. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 127. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 128. ACANDIS: KEY EXECUTIVES
  • TABLE 129. ACANDIS: COMPANY SNAPSHOT
  • TABLE 130. ACANDIS: OPERATING SEGMENTS
  • TABLE 131. ACANDIS: PRODUCT PORTFOLIO
  • TABLE 132. ACANDIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 133. STRYKER: KEY EXECUTIVES
  • TABLE 134. STRYKER: COMPANY SNAPSHOT
  • TABLE 135. STRYKER: OPERATING SEGMENTS
  • TABLE 136. STRYKER: PRODUCT PORTFOLIO
  • TABLE 137. STRYKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 138. MICROPORT SCIENTIFIC: KEY EXECUTIVES
  • TABLE 139. MICROPORT SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 140. MICROPORT SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 141. MICROPORT SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 142. MICROPORT SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 143. CORDIS: KEY EXECUTIVES
  • TABLE 144. CORDIS: COMPANY SNAPSHOT
  • TABLE 145. CORDIS: OPERATING SEGMENTS
  • TABLE 146. CORDIS: PRODUCT PORTFOLIO
  • TABLE 147. CORDIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 148. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 149. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 150. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 151. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 152. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROVASCULAR STENT MARKET SEGMENTATION
  • FIGURE 2. GLOBAL NEUROVASCULAR STENT MARKET
  • FIGURE 3. SEGMENTATION NEUROVASCULAR STENT MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN NEUROVASCULAR STENT MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNEUROVASCULAR STENT MARKET
  • FIGURE 11. NEUROVASCULAR STENT MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. NEUROVASCULAR STENT MARKET FOR CAROTID ARTERY STENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. NEUROVASCULAR STENT MARKET FOR INTRACRANIAL STENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. NEUROVASCULAR STENT MARKET SEGMENTATION, BY BY MATERIAL
  • FIGURE 15. NEUROVASCULAR STENT MARKET FOR METAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. NEUROVASCULAR STENT MARKET FOR POLYMER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. NEUROVASCULAR STENT MARKET SEGMENTATION, BY BY END USERS
  • FIGURE 18. NEUROVASCULAR STENT MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. NEUROVASCULAR STENT MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. NEUROVASCULAR STENT MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 25. COMPETITIVE DASHBOARD
  • FIGURE 26. COMPETITIVE HEATMAP: NEUROVASCULAR STENT MARKET
  • FIGURE 27. TOP PLAYER POSITIONING, 2024
  • FIGURE 28. ABBOTT LABORATORIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 29. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 30. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 31. GORE MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. GORE MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. GORE MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. TERUMO MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. TERUMO MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. TERUMO MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. JOHNSON AND JOHNSON: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. MEDTRONIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. MEDTRONIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. ACANDIS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. ACANDIS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. ACANDIS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. STRYKER: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. STRYKER: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. STRYKER: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. MICROPORT SCIENTIFIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. MICROPORT SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. MICROPORT SCIENTIFIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. CORDIS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. CORDIS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. CORDIS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Neurovascular Stent Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved